Victor Paulus
General Counsel bei HOOKIPA PHARMA INC.
Profil
Victor Paulus is currently the Director at Evergreen Theragnostics, Inc. and the VP & Global Head-Regulatory Affairs at HOOKIPA Pharma, Inc. Previously, he held positions such as Senior Director-Regulatory Affairs at Dr. Reddy's Laboratories Ltd., Elusys Therapeutics, Inc., and GSK Plc.
He also worked as a Manager at Centocor, Inc. and as a Senior Vice President-Regulatory Affairs at Abeona Therapeutics, Inc. Dr. Paulus has a background in regulatory affairs and has experience in various pharmaceutical companies.
He obtained his undergraduate degree from East Stroudsburg University of Pennsylvania and his doctorate degree from Andhra University.
Aktive Positionen von Victor Paulus
Unternehmen | Position | Beginn |
---|---|---|
HOOKIPA PHARMA INC. | General Counsel | 01.09.2018 |
Evergreen Theragnostics, Inc.
Evergreen Theragnostics, Inc. BiotechnologyHealth Technology Evergreen Theragnostics, Inc. manufactures and develops radiopharmaceuticals. It offers 21 CFR 211 compliant commercial manufacturing, nationwide logistics and distribution, technology transfer and method validation and regulatory support services. The company was founded in 2019 and is headquartered in Jersey City, NJ. | Director/Board Member | - |
Ehemalige bekannte Positionen von Victor Paulus
Unternehmen | Position | Ende |
---|---|---|
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | General Counsel | 01.04.2009 |
FUSN PHAR | General Counsel | - |
ABEONA THERAPEUTICS INC. | General Counsel | - |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | General Counsel | - |
ADVANCED ACCELERATOR APPLICATION SA(ADR) | General Counsel | - |
Ausbildung von Victor Paulus
East Stroudsburg University of Pennsylvania | Undergraduate Degree |
Andhra University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
DR. REDDY'S LABORATORIES LIMITED | Health Technology |
GSK PLC | Health Technology |
FUSN PHAR | Health Technology |
HOOKIPA PHARMA INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
Advanced Accelerator Applications SA
Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
Evergreen Theragnostics, Inc.
Evergreen Theragnostics, Inc. BiotechnologyHealth Technology Evergreen Theragnostics, Inc. manufactures and develops radiopharmaceuticals. It offers 21 CFR 211 compliant commercial manufacturing, nationwide logistics and distribution, technology transfer and method validation and regulatory support services. The company was founded in 2019 and is headquartered in Jersey City, NJ. | Health Technology |